“The current predicament has exposed some structural weaknesses within the EU’s medicines source chain and also a high dependence on non-EU nations for active pharmaceutical ingredients,” Kyriakides mentioned. She suggested that offer chain problems be addressed in an EU pharmaceutical approach envisioned being released by the top of your yr.… Read More